Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 14th April 2023
This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-system interactions. We cover the role of AI Daily Roundup and its application in various industries and daily lives.
NVIDIA announced the GeForce RTX 4070 GPU, delivering all the advancements of the NVIDIA Ada Lovelace architecture — including DLSS 3 neural rendering, real-time ray-tracing technologies and the ability to run most modern games at over 100 frames per second at 1440p resolution — starting at $599.
YvesBlue, a leading provider and pioneer of ESG as a Service Platform, is proud to announce the integration of ESG/Sustainability and Generative Artificial Intelligence. This marks a significant milestone in the industry continuing to set YvesBlue apart as a pioneer in providing innovative solutions for financial institutions. Delivering a comprehensive view of ESG/Sustainability across multiple investment workflows and leveraging Generative AI further demonstrates YvesBlue’s focus on transforming data into insight/knowledge.
-Inadequate enterprise case management results in investigator frustration and operational inefficiency. Taking on these challenges, NICE Actimize, a NICE business, launched its ActOne10 Case Management solution to provide financial institutions with the speed, agility, intelligence, and connectivity to lead the way in fighting financial crime. ActOne10 is the next generation of NICE Actimize’s award-winning case manager that is trusted by leading global financial institutions and which supports over 300,000 analysts and investigators daily.
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully discovered a potent, selective, and orally bioavailable small molecule inhibitor of CDK8 for the treatment of cancer using a structure-based generative chemistry approach enabled by the Chemistry42 multi-modal generative reinforcement learning platform. The research was published in the American Chemical Society’s Journal of Medicinal Chemistry, a leading journal in medicinal chemistry.
Sixty-five Percent of Organizations Suffer from Data Bias, According to Progress Research Study
Progress , the trusted provider of application development and infrastructure software, announced the results of its global survey, “Data Bias: The Hidden Risk of AI”. Conducted by independent research firm, Insight Avenue, the Progress survey is based on interviews with more than 640 business and IT professionals, director level and above, who use data to make decisions and are using or plan to use artificial intelligence (AI) and machine learning (ML) to support their decision making.
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.